PRICING OF SERVICES

ArwaDalal GauriBulbule Manasvi Parekh RasikaNatu

What is Pricing of Services?

A pricing system which is based upon revenue sharing between the service provider and client, the basis for service based pricing depends upon the type of industry or product.

COMMON STRATEGY

Pricing Strategy

Competition Costs Value to customer

 PENETRATION

PRICING VALUE BASED PRICING DESTROYER PRICING SKIMMING PSYCHOLOGICAL POINT PRICING LEADER PRICING PRICE BUNDLING

Pricing of drugs
Pricing of drugs is determined by : how unique is the drug? Total R & D cost Competition Other existing treatment And the most important question of all : Does the new drug save or extend life?

Other factors that influence price of a drug

Size

of the market and spending power of customers. Government price controls. Patents

PRICING OF CLINICAL RESREACH ORAGANISATION

SERVICES OFFERED BY CLINICAL RESEARCH ORGANISATION

PRICING OF PEOPLE

PRICING OF PEOPLE

INDIAs DRUG MARKET ENGAGED IN PRICE WAR

The large number of AIDS cases has lured many companies to develop anti-AIDS drugs and market it in India and abroad by adapting innovative approaches to pricing. The anti-AIDS drug market, currently dominated by Mumbai-based Cipla, witnessed the entry of four more pharmaceutical companies including Ranbaxy laboratories, GlaxoSmithKline Pharmaceuticals, Aurobindo Pharmaceuticals and Zydus Cadila in a short span of six months to one year. The rising competition in the domestic anti-AIDS drug market has led to Cipla, a leader in the segment, cut its brand prices five to six times in the last three years. Thus, Cipla triggered a controversy by offering anti-AIDS drugs at a drastically lower prices. Pharmaceutical companies in India are able to gain good healthy revenues, even if these anti-AIDS drugs are sold at steep discounts. India's patent laws currently protect only the processes by which drugs are made but not the products themselves.

REFRENCES: http://www.intertek.com/pharmaceutical/ http://businesstoday.intoday.in/story/new-policy-for -pricing-essential-drugs-likely-by-end-nov2012/1/189239.html

http://www.istockanalyst.com/finance/story/6404188/quintil es-sets-ipo-pricing-between-36-and-40-per-share http://www.fiercebiotech.com/tags/quintiles-0 http://www.ppdi.com/Services/Post-Approval.aspx http://www.technologytransfertactics.com/content/wpcontent/uploads/2009/07/the-top-ten-contract-researchorganizations-brochure.pdf